Posterior reversible encephalopathy syndrome (PRES) and myeloma
Posterior reversible encephalopathy syndrome (PRES) has rarely been described in myeloma, but chemotherapy is a known risk factor. We report 3 patients with myeloma who developed PRES, and analyzed them with 13 published cases, mostly women. The most frequent causative agents were proteasome inhibit...
Main Authors: | Ricardos Ghanem, Sylvie Glaisner, Arthur Bobin, Anne-Marie Ronchetti, Sophie Cereja, Bertrand Joly, Célia Salanoubat, Guillemette Fouquet |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | Leukemia Research Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S221304892300047X |
Similar Items
-
Posterior Reversible Encephalopathy Syndrome (PRES): Pathophysiology and Neuro-Imaging
by: Redmond-Craig Anderson, et al.
Published: (2020-06-01) -
A Case of Posterior Reversibl Encephalopathy Syndrome (PRES) Mimicking Encephalitis
by: Filiz KÜRKLÜ BOZKIR, et al.
Published: (2013-12-01) -
Posterior Reversible Encephalopathy Syndrome (Pres) – A Case Report
by: Melis Türker, et al.
Published: (2011-12-01) -
Posterior Reversible Encephalopathy Syndrome (PRES) in Rheumatic Autoimmune Disease
by: Izzat Khanjar, et al.
Published: (2018-03-01) -
Cyclosporin-A induced Posterior Reversible Encephalopathy Syndrome
by: Saeed Bassam, et al.
Published: (2008-01-01)